AL-53817

N/A

Report date: 2022/11/25 18:07:23

NME

Base Information

Drug NameAL-53817

Drug Alias NameAL-53817

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsHypersensitivityConjunctivitis, Allergic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAlcon

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAlcon

Active IndicationsN/A

Inactive IndicationsHypersensitivityConjunctivitis, Allergic

ATC CodeN/A